Stock listing
Faron Pharmaceuticals Oy
Selected listing: A14355 · LS · EUR · DE
Faron Pharmaceuticals Oy (Lang & Schwarz: A14355), Health Technology. Latest release Oct 6, 2026: Composition of Faron Pharmaceutical’s Shareho.
- Ticker
- Lang & Schwarz: A14355
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Faron Pharmaceuticals Oy
The company focuses on developing innovative treatments in the field of oncology and immunotherapy. Faron is committed to advancing its pipeline of drug candidates to address unmet medical needs in cancer care.
Latest news from Faron Pharmaceuticals Oy
Composition of Faron Pharmaceutical’s Shareho...
October 6, 2026
Faron Announces First Patient Dosed in BLAZE Investigator-Initiated Trial
October 1, 2026
Faron Pharmaceuticals Ltd: Convertible bond amortization payment deferred by mutual agreement with HCM
September 30, 2026
Faron Pharmaceuticals Ltd: Convertible bond a...
September 30, 2026
Faron Pharmaceuticals Oy : Announces R&D Day
September 10, 2026
Research Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy company profile
View the public company page for Faron Pharmaceuticals Oy on 6ix.
Faron Pharmaceuticals Oy news
Read company news and market updates connected to Faron Pharmaceuticals Oy.
Faron Pharmaceuticals Oy investor events
Find investor webinars, events, and replay context for Faron Pharmaceuticals Oy.
Alternate listings
FARN:LSE
GB · GBX
Alternate listing for Faron Pharmaceuticals Oy; the primary context on this page is A14355:LS.
FARON:OMXHEX
FI · EUR
Alternate listing for Faron Pharmaceuticals Oy; the primary context on this page is A14355:LS.
A14355:LSX
DE · EUR
Alternate listing for Faron Pharmaceuticals Oy; the primary context on this page is A14355:LS.
4FR:FWB
DE · EUR
Alternate listing for Faron Pharmaceuticals Oy; the primary context on this page is A14355:LS.